IFNB1 and neoplasm: This is consistent with data from studies exposing STING-expressing tumor cells to the STING agonist cGAMP or dsDNA and finding only low or even absent IFN-β production in mice with chronic lymphatic leukemia and colon cancer cell lines [55,56].